The proteoglycan glycomatrix: A sugar microenvironment essential for complement regulation

Frontiers in Immunology

Volumn 4, Issue NOV, 2013, Pages

  Clark, Simon J ^a   Bishop, Paul N ^a   Day, Anthony J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Complement regulation; Glycomatrix; Glycosaminoglycans; Proteoglycans; Tissue specificity

Indexed keywords

EID: 84890386431     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00412     Document Type: Article

References (27)

1. Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol (2011) 3:a004952. doi: 10.1101/cshperspect.a004952
2. Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J (2006) 20:9-22. doi:10.1096/fj.05-4682rev
3. Schaefer L, Schaefer RM. Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res (2010) 339:237-46. doi:10.1007/s00441-009-0821-y
4. Langford-Smith A, Keenan TDL, Clark SJ, Bishop PN, Day AJ. The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H? J Innate Immun (2013) (in press).
5. Lindahl B, Eriksson L, Lindahl U. Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease. Biochem J (1995) 306:177-84.
6. Clark SJ, Keenan TD, Fielder HL, Collinson LJ, Holley RJ, Merry CL, et al. Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera. Invest Ophthalmol Vis Sci (2011) 52:6511-21. doi:10.1167/iovs.11-7909
7. Keenan TD, Clark SJ, Unwin RD, Ridge LA, Day AJ, Bishop PN. Mapping the differential distribution of proteoglycan core proteins in the adult human retina, choroid, and sclera. Invest Ophthalmol Vis Sci (2012) 53:7528-38. doi:10.1167/iovs.12-10797
8. Coombe DR. Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. Immunol Cell Biol (2008) 86:598-607. doi:10.1038/icb.2008.49
9. Gill S, Wight TN, Frevert CW. Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection. Anat Rec (2010) 293:968-81. doi:10.1002/ar.21094
10. Lortat-Jacob H, Baltzer F, Grimaud JA. Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxy-terminal sequence. J Biol Chem (1996) 271:16139-43. doi:10.1074/jbc.271.27.16139
11. Iida J, Wilhelmson KL, Ng J, Lee P, Morrison C, Tam E, et al. Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP2 (pro-gelatinase A). Biochem J (2007) 403:553-63. doi:10.1042/BJ20061176
12. Sørensen HP, Vivès RR, Manetopoulos C, Albrechtsen R, Lydolph MC, Jacobsen J, et al. Heparan sulfate regulates ADAM12 through molecular switch mechanism. J Biol Chem (2008) 283:31920-32. doi:10.1074/jbc.M804113200
13. Zaferani A, Vivès RR, van der Pol P, Navis GJ, Daha MR, van Kooten C, et al. Factor H and properdin recognize different epitopes on renal tubular epithelial heparan sulfate. J Biol Chem (2012) 287:31471-81. doi:10.1074/jbc.M112.380386
14. Zaferani A, Vivès RR, van der Pol P, Hakvoort JJ, Navis GJ, van Goor H, et al. Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease. J Biol Chem (2011) 286:5359-67. doi:10.1074/jbc.M110.167825
15. Clark SJ, Higman VA, Mulloy B, Perkins SJ, Lea SM, Sim RB, et al. His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem (2006) 281:24713-20. doi:10.1074/jbc.M605083200
16. Clark SJ, Perveen R, Hakobyan S, Morgan BP, Sim RB, Bishop PN, et al. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem (2010) 285:30192-202. doi:10.1074/jbc.M110.103986
17. Clark SJ, Ridge LA, Herbert AP, Hakobyan S, Mulloy B, Lennon R, et al. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J Immunol (2013) 190:2049-57. doi:10.4049/jimmunol.1201751
18. Day AJ, Willis AC, Ripoche J, Sim RB. Sequence polymorphism of human complement factor H. Immunogenetics (1988) 27:211-4. doi:10.1007/BF00346588
19. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 102:7227-32. doi:10.1073/pnas.0501536102
20. Sofat R, Casas JP, Webster AR, Bird AC, Mann SS, Yates JR, et al. Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int J Epidemiol (2012) 41:250-62. doi:10.1093/ije/dyr204
21. Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol (2013) 13:438-51. doi:10.1038/nri3459
22. Prosser BE, Johnson S, Roversi P, Herbert AP, Blaum BS, Tyrrell J, et al. Structural basis for complement factor H-linked age-related macular degeneration. J Exp Med (2007) 204:2277-83. doi:10.1084/jem.20071069
23. Clark SJ, Bishop PN, Day AJ. Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology. Biochem Soc Trans (2010) 38:1342-8. doi:10.1042/BST0381342
24. Day AJ, Clark SJ, Bishop PN. Understanding the molecular basis of age-related macular degeneration and how the identification of new mechanisms may aid the development of novel therapies. Expert Rev Ophthalmol (2012) 6:123-8. doi:10.1586/eop.11.10
25. Williamson KA, Hamilton A, Reynolds JA, Sipos P, Crocker I, Stringer SE, et al. Age-related impairment of endothelial progenitor cell migration correlates with structural alterations of heparan sulfate proteoglycans. Aging Cell (2013) 12:139-47. doi:10.1111/acel.12031
26. Feyzi E, Saldeen T, Larsson E, Lindahl U, Salmivirta M. Age-dependent modulation of heparan sulfate structure and function. J Biol Chem (1998) 273:13395-8. doi:10.1074/jbc.273.22.13395
27. Lee HY, Han L, Roughley PJ, Grodzinsky AJ, Ortiz C. Age-related nanostructural and nanomechanical changes of individual human cartilage aggrecan monomers and their glycosaminoglycan side chains. J Struct Biol (2013) 181:264-73. doi:10.1016/j.jsb.2012.12.008